GLP-1 Agonists | 396
Skip Montreux and Dez Morgan get Down to Business with GLP-1 inhibitors — the drugs behind today’s weight-loss boom. They explain who the main players are, including Novo Nordisk and Eli Lilly, and compare their leading products. The discussion also looks at Pfizer’s acquisition of biopharma startup Metsera, and why this deal could significantly change the market.
GLP-1 Agonists | 396 Read More »




